Unlock instant, AI-driven research and patent intelligence for your innovation.

Prevention of preterm birth (PTB) by inhibition of fkbp51

a technology of fkbp51 and preterm birth, which is applied in the direction of sexual disorder, biochemistry apparatus and processes, drug compositions, etc., can solve the problems of reducing affecting the survival rate reducing the number of infants born prematurely, so as to improve the activity of fkbp51 and enhance the activity of pr

Pending Publication Date: 2022-03-31
UNIV OF SOUTH FLORIDA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The inhibition of FKBP51 effectively prolongs gestation and prevents preterm birth and fetal growth restriction by enhancing progesterone receptor activity, reducing the production of prostaglandins and proteases associated with uterine contractions, and maintaining progesterone levels, thus reducing the likelihood of preterm delivery.

Problems solved by technology

Additionally, racial and ethnic differences in preterm birth rates remain.
Infants born prematurely, especially prior to 32 weeks, have higher rates of death and disability, including, for example, breathing problems, feeding difficulties, cerebral palsy, developmental delays, vision problems, and hearing problems.
Preterm births also exert extreme psychological and financial tolls on affected families.
Preventing preterm birth remains a challenge because there are many causes of preterm birth, and such causes are complex and not always well understood.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Prevention of preterm birth (PTB) by inhibition of fkbp51
  • Prevention of preterm birth (PTB) by inhibition of fkbp51
  • Prevention of preterm birth (PTB) by inhibition of fkbp51

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0046]This example demonstrates the expression pattern of FKBP51 in mice and the effects of FKBP51 regulation on preterm birth (PTB) in mice.

[0047]FKBP51-knockout (KO; FKBP51− / −) and wild type (WT) animals mice (provided by Chad Dickey, PhD; USF Health Morsani College of Medicine) were used to analyze FKBP51 expression and test the hypothesis that FKBP51 regulates preterm birth in mice. To define the role of FKBP51 on birth timing, the gestational length was compared in pregnancies from WT or FKBP51 KO mice mated with WT male littermates (see FIG. 2). This analysis revealed significantly prolonged gestation (more than one day) in KO female mice compared to WT female mice, as shown in FIG. 3, providing the first evidence that FKBP51 regulates gestational length. Moreover, compared to the gestational length in non-stress WT controls, restrained stress significantly reduced gestational length in the stressed WT group (19.10 day vs. 18.72, P=0.018), as shown in FIG. 4, suggesting that g...

example 2

[0052]This example describes experiments comparing corticosterone levels in stressed vs. non-stressed mice.

[0053]In rodents, plasma corticosterone is considered to be the main glucocorticoid involved in regulating stress responses, and the presence of plasma cortisol in serum also has been confirmed in rodents (Gong et al., PLoS One, 10: e0117503 (2015)). The dynamics of mouse serum cortisol and corticosterone may be closely correlated under different physiological or stress conditions, and corticosterone may be a better adaptation-related biomarker than cortisol during chronic stress, whereas cortisol may be a quicker responder than corticosterone during severe acute stress. Therefore, serum corticosterone levels were analyzed in samples obtained from mice tested in Example 1. Blood sampling was performed at 10 to 11 am on gestation days (GDs) 11 after the first stress exposure in WT and KO mice and in non-stressed (control) groups. A commercially available enzyme-linked immunosorb...

example 3

[0054]This example demonstrates the effect of maternal and fetal genotype in stress-induced preterm birth (PTB).

[0055]To investigate the effect of fetal genotype in addition to maternal genotype on stressed reduced gestation length, additional experiments were performed using FKBP51 knockout (KO) female mice mated with FKBP51 KO male mice, which resulted in complete (fetal and maternal) absence of FKBP51 expression during pregnancy. In these experiments, which are illustrated in FIG. 16, female mice were mated with male mice for only 4 hours. The presence of sperm in vaginal smear or vaginal plug was accepted as gestation day (GD) 0. Time-mated pregnant WT and KO mice were randomly assigned to either a stress or control group. Restrained stress was initiated on GD8 and continued until GD18. Time-mated WT and KO pregnant females were monitored between GD18-22, and delivery was checked at 4 hour intervals. The appearance of the first pup was considered the parturition time, and the nu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The disclosure is directed to a method of enhancing progesterone receptor (PR) activity in a mammal, which comprises administering a composition comprising an inhibitor of FK506 binding protein 51 (FKBP51) to a mammal in need thereof, such as a pregnant human female, whereby progesterone receptor activity in the mammal is enhanced as compared to a mammal not administered the composition. The method results in an extension of the gestation period and a decreased likelihood of preterm birth and fetal growth restriction.

Description

CROSS-REFERENCE TO RELATED APPLICATION(S)[0001]This application is a division of application Ser. No. 16 / 488,494, filed Aug. 23, 2019, now U.S. Pat. No. 11,197,868, which is a national stage application filed under 35 U.S.C. § 371 of PCT / US2018 / 019505, filed Feb. 23, 2018, which claims priority to U.S. Provisional Patent Application No. 62 / 463,430, filed on Feb. 24, 2017, which are incorporated herein by reference in their entireties.INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY[0002]Incorporated by reference in its entirety herein is a computer-readable nucleotide / amino acid sequence listing submitted concurrently herewith and identified as follows: One 563 Byte ASCII (Text) file named “210112-9033-WO01-SEQ-LIST-02-23-18.txt,” created on Feb. 23, 2018.BACKGROUND[0003]Preterm birth (PTB) is defined as birth prior to completion of 37 weeks of pregnancy. According to the U.S. Centers for Disease Control and Prevention (CDC), preterm birth rates decreased from 2007 to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/5575A61P15/06
CPCA61K31/5575A61P15/06A61K45/06C12N2310/141A61K31/436A61K31/573A61K31/7105A01K2217/075A01K2227/105A61K2300/00
Inventor LOCKWOOD, CHARLESGUZELOGLU-KAYISLI, ÖZLEMKAYISLI, ÜMITSCHATZ, FREDERICK
Owner UNIV OF SOUTH FLORIDA